The Proteus Discover, an ingestible sensor technology developed by Proteus to monitor treatment efficacy in patients, is currently being trialled in Children’s Health in Dallas, Texas on 15 children recovering from organ transplants. The medication management and adherence system uses a tablet app to display its readings taken via sensor-enabled pills and a wearable peel-and-stick biometric sensor patch. Proteus has also been working with the US Food and Drug Administration (FDA) to develop a new device for monitoring blood sugar levels that can be implanted into patients without their knowledge.
The Proteus Discover, an ingestible sensor technology developed by Proteus to monitor treatment efficacy in patients, is currently being trialled in Children’s Health in Dallas, Texas on 15 children recovering from organ transplants. The medication management and adherence system uses a tablet app to display its readings taken via sensor-enabled pills and a wearable peel-and-stick biometric sensor patch. The hospital plans to release a whitepaper on the trial once finished.